Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Diabetes: Symptoms, Diagnosis, and Complications01:15

Diabetes: Symptoms, Diagnosis, and Complications

2.6K
For most patients, experiencing several weeks of polyuria, polydipsia, fatigue, and significant weight loss may indicate the presence of diabetes. Furthermore, adults displaying the phenotypic appearance of type 2 diabetes (particularly those who are obese and not initially insulin-requiring), may have islet cell autoantibodies, suggesting autoimmune-mediated β cell destruction and a diagnosis of latent autoimmune diabetes of adults (LADA). The categorization of glucose homeostasis is...
2.6K
Diabetes Mellitus: Type 2 and Gestational01:22

Diabetes Mellitus: Type 2 and Gestational

5.3K
Type 2 diabetes, characterized by insulin resistance, arises when the insulin receptors on cells lose responsiveness to insulin, diminishing the cell's capacity to take up glucose, resulting in elevated blood glucose levels. To receive a diagnosis of Type 2 diabetes, a series of blood glucose tests are necessary to assess whether the blood glucose falls within normal parameters. If the result is out of the normal range, a patient may be diagnosed as prediabetic or diabetic, depending on the...
5.3K
Preventive Healthcare Services01:30

Preventive Healthcare Services

2.3K
Preventive healthcare services keep people healthy via frequent check-ups, screening, and counseling. They primarily aid in disease prevention rather than treating an acute or chronic illness. Preventive treatment also keeps individuals productive and energetic, allowing them to work well into their retirement years. Examples of preventive care services include:
2.3K
Insulin: Dosing Regimen and Adverse Effects01:16

Insulin: Dosing Regimen and Adverse Effects

1.0K
Insulin-replacement therapy usually includes both long-acting insulin (basal) and short-acting insulin (to cater to postprandial needs). In a diverse group of type 1 diabetes patients, the average daily insulin dose is typically 0.5-0.7 units/kg body weight. However, obese patients and pubertal adolescents may need more due to insulin resistance.
The basal dose constitutes about 40%-50% of the total daily dose, with the rest as premeal insulin. The mealtime insulin dose should mirror...
1.0K
Diabetes: Management and Pharmacotherapy01:15

Diabetes: Management and Pharmacotherapy

1.2K
The therapy for diabetes aims to alleviate hyperglycemia-related symptoms, prevent acute metabolic decompensation, and reduce chronic end-organ complications. Glycemic control is evaluated through short-term (self-monitoring, continuous glucose monitoring) and long-term (A1c, fructosamine) metrics, enabling near real-time tracking of blood glucose levels and reflecting glycemic control over specific time frames.
Insulin remains the cornerstone of treatment for most patients with type 1 and many...
1.2K
Oral Hypoglycemic Agents: Biguanides and Glitazones01:26

Oral Hypoglycemic Agents: Biguanides and Glitazones

783
Biguanides, particularly metformin (Glucophage), are insulin sensitizers that enhance glucose uptake, thereby reducing insulin resistance. Unlike sulfonylureas, metformin doesn't prompt insulin secretion, which helps to curb hypoglycemia risk. Metformin is beneficial in treating conditions like polycystic ovary syndrome due to its insulin-resistance reduction capability. The drug's primary action involves curtailing hepatic gluconeogenesis, a significant contributor to high blood...
783

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Night shift work as a potential risk factor for hypertensive disorders of pregnancy: the Japan environment and children's study.

International archives of occupational and environmental health·2026
Same author

Infant growth and breastfeeding patterns: The Japan Environment and Children's Study.

Clinical pediatric endocrinology : case reports and clinical investigations : official journal of the Japanese Society for Pediatric Endocrinology·2026
Same author

Abscopal responses following stereotactic ablative radiotherapy during immune checkpoint inhibitor therapy in metastatic renal cell carcinoma: protocol for the prospective multicentre observational AURICRE study in Japan.

BMJ open·2026
Same author

The Missing Step in Fall Prevention: Why Recommendations Fail in Practice.

Journal of general internal medicine·2026
Same author

Giardiasis in Japan, the United States of America, and Europe from 2007 to 2023, highlighting a decline during the COVID-19 pandemic.

PLoS neglected tropical diseases·2026
Same author

Missing by omission: the hidden heart of cardiovascular inequity in the UK.

The British journal of general practice : the journal of the Royal College of General Practitioners·2026

Related Experiment Video

Updated: Mar 11, 2026

A High-Throughput Multiplexed Screening for Type 1 Diabetes, Celiac Diseases, and COVID-19
06:46

A High-Throughput Multiplexed Screening for Type 1 Diabetes, Celiac Diseases, and COVID-19

Published on: July 5, 2022

3.4K

Diabetes screening intervals based on risk stratification.

Sachiko Ohde1,2, Emily McFadden3, Gautam A Deshpande4,5,6

  • 1Center for Clinical Epidemiology, St. Luke's International University, 10-1 Akashi-cho, Chuo, Tokyo, 104-0044, Japan. saohde@luke.ac.jp.

BMC Endocrine Disorders
|November 24, 2016
PubMed
Summary
This summary is machine-generated.

Individualizing Type 2 diabetes mellitus (DM) screening with HbA1c tests is crucial. Higher cardiovascular disease risk and BMI necessitate more frequent screening to prevent overdiagnosis.

Keywords:
Accuracy of testingDiabetes mellitusScreening interval

More Related Videos

Hydra, a Computer-Based Platform for Aiding Clinicians in Cardiovascular Analysis and Diagnosis
07:51

Hydra, a Computer-Based Platform for Aiding Clinicians in Cardiovascular Analysis and Diagnosis

Published on: September 26, 2018

8.2K
Author Spotlight: Understanding Retinal Vessel Resilience and Disease Progression
04:36

Author Spotlight: Understanding Retinal Vessel Resilience and Disease Progression

Published on: January 12, 2024

1.7K

Related Experiment Videos

Last Updated: Mar 11, 2026

A High-Throughput Multiplexed Screening for Type 1 Diabetes, Celiac Diseases, and COVID-19
06:46

A High-Throughput Multiplexed Screening for Type 1 Diabetes, Celiac Diseases, and COVID-19

Published on: July 5, 2022

3.4K
Hydra, a Computer-Based Platform for Aiding Clinicians in Cardiovascular Analysis and Diagnosis
07:51

Hydra, a Computer-Based Platform for Aiding Clinicians in Cardiovascular Analysis and Diagnosis

Published on: September 26, 2018

8.2K
Author Spotlight: Understanding Retinal Vessel Resilience and Disease Progression
04:36

Author Spotlight: Understanding Retinal Vessel Resilience and Disease Progression

Published on: January 12, 2024

1.7K

Area of Science:

  • Endocrinology
  • Preventive Medicine
  • Biostatistics

Background:

  • Current guidelines for Type 2 diabetes mellitus (DM) screening frequency lack specificity, often relying on expert opinion.
  • This study addresses the need for individualized screening intervals based on personal risk factors for diabetes.

Purpose of the Study:

  • To determine optimal HbA1c screening intervals for Type 2 DM based on individual cardiovascular disease risk and BMI.
  • To demonstrate how risk stratification can refine diabetes screening protocols.

Main Methods:

  • A retrospective cohort study of 96,456 healthy adults in Japan (1999-2014).
  • Utilized a signal-to-noise method with a linear random effect model to analyze HbA1c changes.
  • Stratified participants by age, cardiovascular disease risk (Framingham score), and BMI.

Main Results:

  • HbA1c screening intervals decreased significantly with increased risk factors.
  • For 30-44 year olds, intervals shortened from 10.5 years (BMI <18.5) to 2.4 years (BMI >30).
  • Risk scores also correlated with shorter intervals, decreasing from 8.0 years (Score <10%) to 2.0 years (Score ≥20%).

Conclusions:

  • HbA1c screening intervals for Type 2 DM identification are highly variable based on individual risk.
  • Implementing risk stratification is essential for optimizing HbA1c screening intervals in the general population.
  • This approach can help minimize overdiagnosis and overtreatment of diabetes.